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Abstract
Background: Anxiety and depressive disorders are highly prevalent disorders and are mostly treated in primary care.
The management of these disorders by general practitioners is not always consistent with prevailing guidelines because
of a variety of factors. Designing implementation strategies tailored to prospectively identified barriers could lead to
more guideline-recommended care. Although tailoring of implementation strategies is promoted in practice, little is
known about the effect on improving the quality of care for the early recognition, diagnosis, and stepped care treatment
allocation in patients with anxiety or depressive disorders in general practice. This study examines whether the tailored
strategy supplemented with training and feedback is more effective than providing training and feedback alone.
Methods: In this cluster randomised controlled trial, a total of 22 general practices will be assigned to one of two
conditions: (1) training, feedback, and tailored interventions and (2) training and feedback. The primary outcome measure
is the proportion of patients who have been recognised to have anxiety and/or depressive disorder. The secondary
outcome measures in patients are severity of anxiety and depressive symptoms, level of functioning, expectation towards
and experience with care, quality of life, and economic costs. Measures are taken after the start of the intervention at
baseline and at three- and six-month follow-ups. Secondary outcome measures in general practitioners are adherence to
guideline-recommended care in care that has been delivered, the proportion of antidepressant prescriptions, and
number of referrals to specialised mental healthcare facilities. Data will be gathered from the electronic medical patient
records from the patients included in the study. In a process evaluation, the identification of barriers to change and the
relations between prospectively identified barriers and improvement interventions selected for use will be described, as
well as the factors that influence the provision of guideline-recommended care.
Discussion: It is hypothesised that the adherence to guideline recommendations will be improved by designing
implementation interventions that are tailored to prospectively identified barriers in the local context of general
practitioners. Currently, there is insufficient evidence on the most effective and efficient approaches to tailoring,
including how barriers should be identified and how interventions should be selected to address the barriers.
Trial registration: NTR1912
Background
Anxiety and depressive disorders are common mental
disorders that have a negative impact on everyday func-
tioning, cause great suffering, and incur both high
healthcare costs and additional costs associated with
production losses [1-3]. The lifetime prevalence of anxi-
ety and depressive disorders in Dutch adults is about
20%, and the 12-month prevalence is 10% and 5% [4],
respectively. Most adults who seek help for their anxiety
or depressive disorder are treated in general practice
[5,6].
In the Netherlands, clinical guidelines are available for
both anxiety and depressive disorders for general prac-
tice [7-10]. Enhancing guideline adherence is expected
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improvement of social functioning [11,12]. The manage-
ment of anxiety and depressive disorders by general
practitioners (GPs) is not always consistent with prevail-
ing guidelines. Under-recognition and consequently
under-treatment of anxiety and depressive disorders
have been reported, where threshold disorders are more
likely to be recognised than are subthreshold disorders
[5,13-15]. About a quarter and a half of patients, respec-
tively, receive optimal treatment for an anxiety disorder
and a depressive disorder in primary care [16,17].
Besides under-diagnosis and under-treatment in some
patients, other patients are over-treated with psycho-
pharmacological drugs, while these are not indicated
[5,18,19]. Use of effective early interventions in patients
with mild problems, which are often based on cognitive
behavioural techniques, is more the exception than the
rule [20]. The adherence to guideline recommendations
is suboptimal because of a variety of factors influencing
GPs’ recognition and management of anxiety and
depressive disorders. These factors are related to (a)
patients, such as lack of recognition of having a psycho-
logical problem, presentation of physical symptoms,
absence of a perceived need for care; (b) GPs, for exam-
ple, lack of knowledge and skills, attitudes, time, self-
efficacy, patient-physician communication; and (c) orga-
nisation of care, such as insufficient collaboration with
mental health professionals and waiting lists for speci-
alty mental healthcare [21-26]. In addition, some recom-
mendations in the guidelines have less support from
research evidence or may be perceived as less attractive.
To improve adherence to guideline recommendations,
various implementation strategies can be effective for
improving professional performance in healthcare profes-
sionals [27]. Many quality-improvement interventions in
anxiety and depression care target provider knowledge
through education on treatment guidelines and continu-
ous performance feedback or they contain a fixed package
of multiple strategies, such as in the Quality Improvement
Collaboratives [28,29]. Other interventions in anxiety and
depression care target organisation of healthcare delivery,
for instance, by involving mental health consultants
[22,30]. The strategies show mixed and overall moderate
effects on clinical management of depression and out-
comes in primary care.
Our hypothesis is that adherence to guideline recom-
mendations, and consequently patient outcomes, will be
improved by designing implementation interventions that
are tailored to prospectively identified barriers in the local
context of GPs [23,25,31-33]. The choice of a study in tai-
lored implementation is based on the assumption that
implementation is affected by impeding local factors
related to care professionals, the organisation of care, and
social factors. Successful implementation is only possible
when these barriers are dealt with through an implemen-
tation plan tailored to the situation [34]. Different studies
have investigated the impact of tailored interventions for
behaviour change in GPs, to improve the quality of care,
in randomised controlled trials (RCTs) [32]. Because the
tailoring methods used in these studies are heterogeneous,
there is insufficient evidence on the most effective and effi-
cient approaches to tailoring, including how barriers
should be identified and how interventions should be
selected to address the barriers. Therefore, we used a prag-
matic and flexible approach of tailoring implementation to
barriers to change.
This article describes the aims and methods of an
RCT to determine the effectiveness of tailored inter-
ventions in the implementation of guideline recom-
mendations for the early recognition, diagnosis, and
stepped-care treatment allocation in patients with
anxiety or depressive disorders in general practice in
the Netherlands.
Methods/design
Objectives
The primary aim of this RCT is to determine the effec-
tiveness of tailored interventions to improve the imple-
mentation of guideline recommendations for the early
recognition, diagnosis, and stepped-care treatment allo-
cation for anxiety and depressive disorders in general
practice. Secondary aims are to describe the identifica-
tion of barriers for improving professional performance,
the relationship between prospectively identified barriers
and improvement interventions selected for use, and the
influencing factors and experiences with the strategy.
The final aim is to examine the efficiency of the tailored
intervention compared to usual care from a societal per-
spective with a time horizon of six months.
Time frame
This study was initiated in 2009 and is planned to take
3.5 years.
Study design
A cluster RCT with two arms has been chosen for this
study. Cluster randomisation was applied at the level of
the general practice organisation. The general practice
organisations were allocated to the intervention or the
control group. The allocation was generated by an inde-
pendent statistician.
The chosen implementation strategies are
1. an educational intervention targeted at GPs, com-
prising of one day of training at the start and one feed-
back at six months (in both study arms);
2. one or more interventions tailored to prospectively
identified barriers in the local context of GPs (only in
the intervention arm).
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We aimed at recruiting patients and GPs in 22 general
practices into our trial. Therefore, we prepared a news-
letter for GPs with information about the goals of the
study; the activities; and the accreditation they would
receive if they followed the one-day training in guideline
recommendations for the early recognition, diagnosis,
and stepped-care treatment allocation of patients with
anxiety or depressive disorders. Several recruitment stra-
tegies were carried out: (a) the newsletter was published
at the website of the Dutch GPs association and the
website of the Trimbos Institute, a centre of expertise
on mental health and addiction and (b) the newsletter
was sent to a sample of 500 GPs, provided by the Neth-
erlands Institute for Health Services Research (NIVEL)
and to all GPs who had a contract with a specific health
insurance company that gives financial support. Subse-
quently, a researcher contacted all practices by phone to
recommend participation. Finally, 23 general practices
were included.
Recruitment of patients
We aimed at including patients with symptoms that might
indicate anxiety or depressive disorders. A sample of
patients who visit their GP from September 2010 will
receive an information letter with an invitation to partici-
pate and will be asked to fill out a short screening instru-
ment: the extended Kessler-10 (EK-10). The Dutch EK-10
is a validated screening instrument for anxiety and depres-
sive disorders in primary care [35]. Of those patients who
return the EK-10 and give informed consent to call for the
provision of further information about the study, the score
on the EK-10 will be calculated. Patients are considered
screen-positive if the score is 20 or higher and/or they
ticked at least once a ‘yes’ on the added questions 11
through 16. Screen-positive patients will be called and
given further information about the study. Patients who
do not meet the exclusion criteria will receive a second
information letter, the baseline questionnaire, and a sec-
ond informed consent form. Patients will be given the
option to complete the questionnaire in writing or digi-
tally. Inclusion in the study will be definite if the patient
returns the baseline questionnaire and gives informed con-
sent for participation in the study. GPs are not informed
about the inclusion of their patient. Figure 1 shows a flow-
chart of participating patients.
Patient inclusion and exclusion criteria
Inclusion criteria are an age of 18 years and older, a score
on the Dutch version of the EK-10 of 20 or higher, and/or
at least one yes on the added questions 11 through 16.
Exclusion criteria are an age under 18 years, suicidal idea-
tions, dementia or other severe cognitive disorders, psy-
chotic disorder, bipolar disorder, dependence on alcohol
or drugs, unstable severe medical condition as diagnosed
by their GP, insufficient knowledge of the Dutch language
to fill out the questionnaires, or having received psycholo-
gical treatment in the six months before the start of the
study or recognised with anxiety or depressive symptoms
by their GPs in this period.
Screening with Extended 
Kessler-10 +
1st informed consent
No response 
Excluded
negative Extended 
Kessler-10
Telephone contact:
 further information about 
study and check inclusion 
criteria
2nd informed consent
Time 1 questionnaires
(3 months)
Time 2 questionnaires
(6 months)
No 2nd informed consent
No response Time 1
No response Time 2
Excluded:
Not meeting inclusion 
criteria
Not wanting to participate
Time 0 questionnaires
No response Time 0
Figure 1 Flowchart of participating patients.
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The primary outcome measure for the evaluation of the
effectiveness of tailored interventions is the recognition
of anxiety or depressive disorders by GPs in patients
with symptoms that might indicate these conditions.
The rate of recognition was reported at about 45%
[14,36]. Studies showed that interventions focused on
professionals’ adherence to guidelines can increase
adherence by 10% [27]. With tailored interventions, we
suppose the recognition can improve by 15%. To get an
accurate estimate (alpha = 0.05; power = 0.80) of a 15%
difference (45% vs. 60%) in recognition between both
groups, assuming that 5% of participants will drop out
(loss to follow-up will be minimal because we will per-
form a retrospective medical record search to get insight
in rate of recognition) and considering an intracluster
correlation of 0.01 [37], 396 patients in 22 practices
have to be included.
Intervention group
Tailored strategies
GPs from the general practices randomised to the inter-
vention group will receive interventions that are tailored
to prospectively identified barriers in their local context
over the course of one year. Methods for tailoring imple-
mentation interventions to local barriers vary widely and
are often poorly documented [31]. To get insight in the
experienced barriers in the early recognition, appropriate
diagnosis, stepped-care treatment allocation, and provid-
ing of information on the diagnosis and stepped-care
treatment options for anxiety and depressive disorders, a
semistructured face-to-face interview was carried out with
each of the participating GPs by a trained interviewer. For
this interview, we developed a checklist based on the main
types of barriers to adherence to evidence-based guidelines
on anxiety and depressive disorders by GPs [25,28,38].
Based on these main types of barriers, we developed inter-
ventions that could solve the barriers. Each interview was
documented in a report. Based on this report, experts sug-
gest interventions that may resolve the barriers. These
interventions are fed back by telephone to the GP by the
same interviewer.
The interviewer calls the GP once every two months
to map the implementation process and links this back
to the experts. Again, experts suggest interventions or
give advice to the interviewer for the next contact with
the GP. With a continuous feedback loop between the
experts, the interviewer, and the GP, we optimise the
tailoring process. All contacts between the experts, the
GP visitor, and the GP are reported.
Training
GPs in both conditions received one day of training by
experts in (a) the early recognition of high-risk patients
with the Four-Dimensional Symptom Questionnaire
(4DSQ), (b) appropriate diagnosis, (c) stepped-care treat-
ment allocation, and (d) the providing of information to
patients with anxiety and depressive disorders. The
4DSQ is a self-rating questionnaire measuring four
dimensions of common psychopathology: distress,
depression, anxiety, and somatization. The 4DSQ was
developed in general practice. The principal aim of the
4DSQ is to distinguish between stress-related syndromes
(denoted as ‘stress’, ‘burnout’, ‘nervous breakdown’)a n d
psychiatric disorders (i.e., depression and anxiety disor-
ders) [39]. The 4DSQ can be used in recognising high-
risk patients for anxiety or depressive disorders and is
recommended by the multidisciplinary guidelines on
anxiety and depressive disorders. Criteria for high-risk
patients are described in the clinical guidelines for anxi-
ety and depressive disorders for general practice. In a for-
mer quality-improvement project, GPs showed positive
experiences with the use of the 4DSQ in detecting anxi-
ety disorders. The 4DSQ offers GPs a means to start talk-
ing with patients with unexplained somatic symptoms
about possible psychological or psychiatric disorders.
Adequate diagnosis is based on the recommendations
of clinical guidelines for general practice. Stepped-care
treatment allocation is based on the multidisciplinary
guidelines. According to the stepped-care model, patients
with a noncomplex anxiety disorder or a nonsevere
depressive disorder have to receive as a first step brief
interventions, such as guided self-help or brief therapy.
Patients with a complex anxiety disorder or a severe
depressive disorder have to receive effective psychothera-
peutic interventions, an antidepressant, or a combination
of both. Determination of the complexity of an anxiety
disorder is based on at least one of the following criteria:
serious social/functional dysfunction, comorbidity
(patient has another anxiety disorder or depression),
obsessive compulsive disorder or posttraumatic stress
disorder, no response after a minimum of six weeks and
maximum 18 weeks, or no remission after a first-step
brief intervention. Determination of the severity of a
depressive disorder is based on at least one of the follow-
ing criteria: high level of distress, serious social/func-
tional dysfunction, minimum eight symptoms of the
depressive disorder according to the fourth edition of the
Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) [40], psychotic features, suicidal ideation.
Feedback
GPs in both conditions were asked to fill out a consulta-
tion registration form for each patient who completed
the 4DSQ. On this form, GPs need to register the score
on the 4DSQ, the diagnosis, the indicated treatment,
and if they informed the patient about the diagnosis and
stepped-care treatment options. GPs received individual
feedback on the number of registered 4DSQs, appropri-
ate diagnosis, stepped-care treatment allocation, and
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ment options in a report after six months, based on the
consultation registration forms.
Control group
GPs from the general practices randomised to the con-
trol group only received training and feedback (see
intervention group).
Outcome measures
Primary outcome
The primary outcome for both conditions is the propor-
tion of patients who have been appropriately recognised to
have anxiety and/or depressive disorder. This proportion
is calculated by dividing the amount of patients recognised
by the GP by the total amount of patients included in the
study. Recognition is measured by the registration of (a)
anxiety or depressive complaints; (b) psychological com-
plaints (anxiety, worrying, sorrow/grief, stress, feeling
down and sleeping disorder, unexplainable somatic com-
plaints); (c) the International Classification of Primary
Care-1 (ICPC-1) codes [41] for anxiety and/or depression
and/or related psychological problems, the same ICPC
codes that were used in previous work by Smolders [17];
and (d) the 4DSQ score.
Secondary outcomes
In patients
The secondary outcome measures in patients are severity
of anxiety and depressive symptoms measured with the
4DSQ; level of functioning, measured with the World
Health Organization’s Disability Assessment Scale II [42];
expectation towards and experience with care, measured
with the QUality Of care Through the Eyes of the patient
(QUOTE) [43]; care utilisation, illness, and work, mea-
sured with the Trimbos/institute Medical Technology
Assessment questionnaire for Costs associated with Psy-
chiatric Illness (TiC-P) [44]; and quality of life, measured
with the EuroQol (EQ-5D) [45]. Measurement will take
place every three months: at baseline (T0) and at three
(T1) and six months (T2) after inclusion.
In general practice
The secondary outcome measures for both conditions are
proportion of patients for whom tricyclic antidepressants
(TCA’s) or selective serotonin reuptake inhibitors were
prescribed and number of referrals to specialised mental
healthcare. We gather data to calculate the secondary
outcomes by performing a retrospective patient medical
record search, after the last patient’s follow-up measure.
Process evaluation
In a process evaluation, we describe the identification of
barriers to change and the relationships between prospec-
tively identified barriers and improvement interventions
selected for use in the intervention group. We evaluate the
experiences of GPs in the intervention group, the GP
visitors and the experts with the tailoring process, the
implemented changes in practice, and the factors influen-
cing the tailoring process. To measure the experiences,
semistructured interviews are conducted, and reports of
the interviews are made.
To get an insight into the factors that influence the pro-
vision of guideline-recommended care in both groups, all
GPs are asked to fill out an individual self-administered
questionnaire about the general practice and GP character-
istics. The practice characteristics include practice type,
number of GPs in the practice, collaboration with other
healthcare professionals working in the practice, and size
of practice population. The GP characteristics include
demographic data, interest and attitudes towards depres-
sive and anxiety disorders, and questions to assess barriers
to healthcare provision to patients with depressive or anxi-
ety disorders and, for implementation of the depression
and anxiety guidelines, collaboration with professionals
and institutions specialised in mental healthcare and GPs’
levels of burnout. This questionnaire is developed and
used in the Netherlands Study of Depression and Anxiety,
an eight-year longitudinal cohort study designed to be
representative of persons with depressive and anxiety dis-
orders in different healthcare settings and in different
stages of the disorders [24,46]. The questionnaire is filled
out twice: before the start of the tailoring process and
when the tailoring process is finished.
Economic evaluation
An economic evaluation will be conducted to estimate the
cost effectiveness of the tailored intervention from a socie-
tal perspective. The between-group difference in costs will
be related to the difference in benefits in terms of health-
related utilities. This economic evaluation uses the EQ-5D.
The cost-utility analysis measures health in quality-
adjusted life years (QALYs), derived using the EQ-5D
questionnaire [47]. The EQ-5D characterises five health
dimensions (mobility, self-care, usual activities, pain, and
anxiety/depression), each rated using three levels (no pro-
blems, moderate, and severe problems). Responses will be
transformed into a health utility score that ranges between
0 = dead and 1 = full health. Health utilities will then be
used to calculate the QALYs. This gives a comparison of
how many QALYs individuals in each group gained on
average as a result of the tailored intervention. Results can
statistically be compared to see if there are any differences.
The final step of the cost-utility analysis will be to com-
pare the cost of the QALY gains in each group.
The costs of the implementation strategy used will be
studied for each practice. These costs are (a) the costs
per hour of the GP visitor and experts for the activities
during the tailoring process and the one-day training and
feedback, (b) material costs for the one-day training, and
(c) the costs per hour of the GP related to the implemen-
ted interventions. In addition, the difference in healthcare
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including number of consultations, diagnostic tests, and
referrals with diagnostic aims. Healthcare costs will be
measured by the TiC-P. The costs will be estimated in
line with the Dutch guidelines for cost calculations in
healthcare [48].
Apart from costs of the tailored strategy, healthcare
costs, and costs of production losses, indirect costs will
be measured for both groups related to the severity of
anxiety and depressive symptoms, level of functioning,
experience with care, and quality of life.
Statistical analyses
The adequacy of randomisation is assessed comparing
characteristics of the general practice and GPs that might
influence the outcomes (see process evaluation). Recogni-
tion of anxiety or depressive disorders in eligible patients
in the study period is compared between the intervention
and control groups, taking into account clustering of data
in a multilevel regression model. We will also calculate and
compare the percentages of patients who have been appro-
priately recognised and diagnosed, prescribed antidepres-
sants, and referred and the number of consultations,
determined by the registration in patients’ medical records.
Descriptive statistics will be used to outline the charac-
teristics of practices and GPs. Finally, bivariate and multi-
variate multilevel regression analyses will be performed to
identify factors associated with better adherence to specific
guideline recommendations. All analyses will be per-
formed on an intention-to-treat basis. Possible confound-
ing characteristics (e.g., age, gender) will be included in the
statistical models.
In addition, we will describe the barriers for change that
were identified and the relationships between prospec-
tively identified barriers and improvement interventions
selected for use, based on an analysis of the records from
the contacts between the GP and the interviewer. Data
about the experiences of participants in the tailoring pro-
cess, the implemented changes in practice, and their ideas
about influencing factors will be structured, interpreted,
and described in a qualitative way.
Direct and indirect costs of the interventions will be
reported. The results of the cost will be presented as mean
values with standard errors. Cost effectiveness will be pre-
sented in incremental cost-effectiveness ratios. The uncer-
tainty will be assessed using bootstrapping, and
acceptability curves will be presented [49]. A principled
method for dealing with missing data will be applied to
the economic evaluation [50].
Ethical principles
The study protocol has been approved by the Medical
Ethical Committee of the Institutions for Mental Health
(METiGG; Utrecht, the Netherlands) in 2009.
Discussion
Early recognition, diagnosis, and stepped-care treatment
allocation in patients with anxiety or depressive disorders
in general practice is dependent on a variety of factors
influencing GP performance. The study gives information
about the relevant barriers for improvement and whether
they differ between GPs. Designing implementation inter-
ventions that are tailored to prospectively identified barriers
for improvement in the local context of GPs could lead to
more guideline-recommended care. Different studies have
investigated the impact of tailored interventions for beha-
viour change in GPs, to improve the quality of care, in an
RCT, but little is known about what methods and models
of tailoring are effective and efficient [31,32]. The aim of
this RCT is to determine the effectiveness of tailored inter-
ventions to improve the implementation of guideline
recommendations for the early recognition, diagnosis, and
stepped-care treatment allocation for anxiety and depres-
sive disorders in primary care and describe the methods
used in the process of tailoring. Because the performance of
GPs during the tailoring process may be influenced by pol-
icy developments, personal attention, or even external
financial incentives, the relationships between prospectively
identified barriers and improvement interventions selected
for use will be described, as well as the factors that influ-
ence the provision of guideline-recommended care.
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